Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
TransMedics Group ( (TMDX) ) has provided an announcement.
TransMedics Group, Inc. has appointed Gerardo Hernandez as the new Chief Financial Officer, effective December 2, 2024, succeeding Stephen Gordon. Hernandez brings over 25 years of financial experience across healthcare and consumer sectors, having previously held significant roles at Alnylam Pharmaceuticals and Shire. The company also updated its 2024 financial outlook, projecting substantial revenue growth. This strategic leadership change aims to enhance TransMedics’ operations and expand its market influence in organ transplantation technologies.
See more data about TMDX stock on TipRanks’ Stock Analysis page.